Page last updated: 2024-09-05

scutellarin and Amyloid Deposits

scutellarin has been researched along with Amyloid Deposits in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
An, H; Dou, F; Huang, Y; Lai, Y; Liu, W; Peng, D; Shao, W; Wang, L; Wei, D; Yang, T; Zhang, J; Zhang, S; Zhang, Z1

Other Studies

1 other study(ies) available for scutellarin and Amyloid Deposits

ArticleYear
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 121

    Topics: Amyloid beta-Peptides; Animals; Apigenin; Cognitive Dysfunction; Drugs, Chinese Herbal; Glucuronates; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice, Inbred C57BL; Mice, Transgenic; Molecular Weight; Plaque, Amyloid; Presenilin-1; Protein Aggregates; Protein Multimerization; Solubility

2020